Cargando…
Hepatitis C mortality trends in San Francisco: can we reach elimination targets?
PURPOSE: Hepatitis C virus (HCV) is the most common blood-borne infection in the United States, and a leading cause of liver disease, transplant, and mortality. CDC HCV elimination goals include reducing HCV-related mortality by 65% (from 2015) by 2030. METHODS: We used vital registry data (CDC WOND...
Autores principales: | Mirzazadeh, Ali, Facente, Shelley N., Burk, Katie, Kahn, James G., Morris, Meghan D. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9293250/ https://www.ncbi.nlm.nih.gov/pubmed/34700016 http://dx.doi.org/10.1016/j.annepidem.2021.10.004 |
Ejemplares similares
-
Estimated hepatitis C prevalence and key population sizes in San Francisco: A foundation for elimination
por: Facente, Shelley N., et al.
Publicado: (2018) -
Correction: Estimated hepatitis C prevalence and key population sizes in San Francisco: A foundation for elimination
por: Facente, Shelley N., et al.
Publicado: (2018) -
Hepatitis C prevalence and key population size estimate updates in San Francisco: 2015 to 2019
por: Facente, Shelley N., et al.
Publicado: (2022) -
Progress toward closing gaps in the hepatitis C virus cascade of care for people who inject drugs in San Francisco
por: Mirzazadeh, Ali, et al.
Publicado: (2021) -
Psychosocial Determinants of HIV Stigma among Men Who Have Sex with Men in San Francisco, California
por: Bhatta, Dharma N., et al.
Publicado: (2021)